Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 28, 2021 Filed Jun 2, 2021 20:07 UTC |
Scadden DavidDirector
|
Exercise / conversionCommon stock | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000051 · wf-form4_162266443793602.xml · nonDerivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:06 UTC |
Ho MaykinDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000049 · wf-form4_162266438962941.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F2 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:06 UTC |
Ho MaykinDirector
|
Exercise / conversionCommon stock | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000049 · wf-form4_162266438962941.xml · nonDerivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:07 UTC |
Schenkein David PDirector
|
Exercise / conversionRestricted stock units · Derivative | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000050 · wf-form4_162266441654458.xml · derivative · entry 4 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. F4 · derivative.expiration_date: The restricted stock units were granted on May 28, 2020. The shares underlying the stock units will vest in full on May 28, 2021. Vested shares will be delivered to the reporting person within three businessdays after such shares become vested. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 20:07 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 1,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000050 · wf-form4_162266441654458.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
MARAGANORE JOHNDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000047 · wf-form4_162188912899512.xml · derivative · entry 2 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
MARAGANORE JOHNDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000047 · wf-form4_162188912899512.xml · derivative · entry 1 MARAGANORE JOHN · CIK 0001180432 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:46 UTC |
Scadden DavidDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000048 · wf-form4_162188914901072.xml · derivative · entry 2 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:46 UTC |
Scadden DavidDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000048 · wf-form4_162188914901072.xml · derivative · entry 1 Scadden David · CIK 0001707715 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
Schenkein David PDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000046 · wf-form4_162188910802212.xml · derivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
Schenkein David PDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000046 · wf-form4_162188910802212.xml · derivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
Foster-Cheek Kaye IDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000045 · wf-form4_162188908499200.xml · derivative · entry 2 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:45 UTC |
Foster-Cheek Kaye IDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000045 · wf-form4_162188908499200.xml · derivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
CLARK IAN TDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000044 · wf-form4_162188906703908.xml · derivative · entry 2 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
CLARK IAN TDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000044 · wf-form4_162188906703908.xml · derivative · entry 1 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
Clancy Paul JDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000043 · wf-form4_162188904410902.xml · derivative · entry 2 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
Clancy Paul JDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000043 · wf-form4_162188904410902.xml · derivative · entry 1 Clancy Paul J · CIK 0001409601 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
Ho MaykinDirector
|
GrantStock options (right to buy) · Derivative | 8,888 | $0.00 Strike: $56.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000042 · wf-form4_162188902273056.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,888 Underlying: Common stock · 8,888 shares Expires 2031-05-20 F3 · derivative.exercise_date: This option was granted on May 20, 2021. The shares underlying this option vest as to 100% of the underlying shares on May 20, 2022. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:44 UTC |
Ho MaykinDirector
|
GrantRestricted stock unit · Derivative | 1,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000042 · wf-form4_162188902273056.xml · derivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,585 Underlying: Common stock · 1,585 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested F2 · derivative.expiration_date: The restricted stock units were granted on May 20, 2021. The shares underlying the stock units will vest in full on May 20, 2022. Vested shares will be delivered to the reporting person within three business days after such shares become vested Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:11 UTC |
Miles DarrinChief Commercial Officer
|
SaleCommon stock | 3,462 | $55.41 | $191,829.42 |
DisclosureSEC source: 0001439222-21-000041 · wf-form4_162136864414651.xml · nonDerivative · entry 1 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,209 F1 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.40 to $55.47. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 1,888 | $0.00 Strike: $39.76 | $0.00 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · derivative · entry 8 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,332 Underlying: Common stock · 1,888 shares Expires 2026-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option was granted on February 16, 2016. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 12,513 | $0.00 Strike: $35.16 | $0.00 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · derivative · entry 7 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 12,513 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was granted on May 31, 2014. The shares underlying this option vest as to 25% of the underlying shares on May 13, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
SaleCommon stock | 14,401 | $55.11 | $793,581.51 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · nonDerivative · entry 5 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,487 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.34. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 1,888 | $39.76 | $75,066.88 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · nonDerivative · entry 4 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 20, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 12,513 | $35.16 | $439,957.08 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · nonDerivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionStock option (right to buy) · Derivative | 3,210 | $0.00 Strike: $35.16 | $0.00 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · derivative · entry 6 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,513 Underlying: Common stock · 3,210 shares Expires 2024-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was granted on May 31, 2014. The shares underlying this option vest as to 25% of the underlying shares on May 13, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
SaleCommon stock | 3,210 | $55.16 | $177,054.61 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,487 F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $55.00 to $55.40. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 3,210 | $35.16 | $112,863.60 |
DisclosureSEC source: 0001439222-21-000036 · wf-form4_161903949035322.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 77 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| April 16, 2021 Filed Apr 20, 2021 16:10 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 1,118 | $55.89 | $62,485.02 |
DisclosureSEC source: 0001439222-21-000035 · wf-form4_161894939327254.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 15, 2021 Filed Apr 16, 2021 16:33 UTC |
Alenson CarmanPrincipal Accounting Officer
|
SaleCommon stock | 991 | $54.00 | $53,514.00 |
DisclosureSEC source: 0001439222-21-000034 · wf-form4_161860518490311.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,118 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: Includes 314 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| March 05, 2021 Filed Mar 16, 2021 20:14 UTC |
Miles DarrinChief Commercial Officer
|
SaleCommon stock | 500 | $48.58 | $24,290.00 |
DisclosureSEC source: 0001439222-21-000031 · wf-form4_161592564145666.xml · nonDerivative · entry 2 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,671 Read SEC document |
| March 01, 2021 Filed Mar 16, 2021 20:14 UTC |
Miles DarrinChief Commercial Officer
|
SaleCommon stock | 2,200 | $47.99 | $105,578.00 |
DisclosureSEC source: 0001439222-21-000031 · wf-form4_161592564145666.xml · nonDerivative · entry 1 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,171 F1 · balance_after: Includes 314 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| February 24, 2021 Filed Feb 24, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Tax withholdingCommon stock | 986 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000020 · wf-form4_161420108188627.xml · nonDerivative · entry 2 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,410 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 16:12 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000021 · wf-form4_161420111004318.xml · derivative · entry 3 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 691 Underlying: Common stock · 692 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 16:12 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Tax withholdingCommon stock | 199 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000021 · wf-form4_161420111004318.xml · nonDerivative · entry 2 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,795 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 16:12 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionCommon stock | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000021 · wf-form4_161420111004318.xml · nonDerivative · entry 1 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionRestricted stock units · Derivative | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000023 · wf-form4_161420118102035.xml · derivative · entry 3 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 724 Underlying: Common stock · 725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Tax withholdingCommon stock | 215 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000023 · wf-form4_161420118102035.xml · nonDerivative · entry 2 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,057 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionCommon stock | 725 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000023 · wf-form4_161420118102035.xml · nonDerivative · entry 1 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:12 UTC |
Schenkein David PDirector
|
Exercise / conversionRestricted stock units · Derivative | 2,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000022 · wf-form4_161420115567750.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,775 Underlying: Common stock · 2,774 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:12 UTC |
Schenkein David PDirector
|
Tax withholdingCommon stock | 821 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000022 · wf-form4_161420115567750.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,591 Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:12 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 2,774 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000022 · wf-form4_161420115567750.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000020 · wf-form4_161420108188627.xml · derivative · entry 3 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common stock · 3,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 21:11 UTC |
Bowden ChristopherChief Medical Officer
|
Exercise / conversionCommon stock | 3,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000020 · wf-form4_161420108188627.xml · nonDerivative · entry 1 Bowden Christopher · CIK 0001608601 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:13 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 790 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000010 · wf-form4_161359638023953.xml · derivative · entry 5 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on February 16,2018. The shares underlying the restricted stock units will vest in three equal annual installments on February 16, 2019, 2020 and 2021. F3 · derivative.expiration_date: The restricted stock units were granted on February 16,2018. The shares underlying the restricted stock units will vest in three equal annual installments on February 16, 2019, 2020 and 2021. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:13 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Tax withholdingCommon stock | 561 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000010 · wf-form4_161359638023953.xml · nonDerivative · entry 3 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 16:13 UTC |
Alenson CarmanPrincipal Accounting Officer
|
Exercise / conversionCommon stock | 790 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000010 · wf-form4_161359638023953.xml · nonDerivative · entry 2 Alenson Carman · CIK 0001688865 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionRestricted stock units · Derivative | 922 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000013 · wf-form4_161359645668070.xml · derivative · entry 5 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 922 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units vest in three equal annual installments. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Tax withholdingCommon stock | 2,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000013 · wf-form4_161359645668070.xml · nonDerivative · entry 3 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,547 Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Miles DarrinChief Commercial Officer
|
Exercise / conversionCommon stock | 922 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-21-000013 · wf-form4_161359645668070.xml · nonDerivative · entry 2 Miles Darrin · CIK 0001840076 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.